Lanean...

New developments in the treatment of multiple myeloma – clinical utility of daratumumab

Multiple myeloma is a clonal disorder of plasma cells that is currently considered incurable. CD38 is a 46 kDa type II transmembrane glycoprotein that is highly expressed on myeloma cells. Daratumumab is a first in-class human IgG1 monoclonal antibody that targets CD38, and has antimyeloma effects t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biologics
Egile Nagusiak: McEllistrim, Cian, Krawczyk, Janusz, O’Dwyer, Michael E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2017
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5395289/
https://ncbi.nlm.nih.gov/pubmed/28442888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S97633
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!